RFP QuestBeta
ClosedStage · preprocurement

CELL AND GENE THERAPY CATAPULT

Premarket Engagement Specification for Transmission electron cryomicroscopy assay (Cryo-TEM Assay)

R&DCPV 73111000
ValueValue not published
Deadline12 Sept 2023
Published22 Aug 2023
RegionNationwide
Timeline
Published 22 Aug 2023ClosedCloses 12 Sept 2023
When this comes round again

CELL AND GENE THERAPY CATAPULT publishes Research & Development work continuously — 5 notices, roughly one every 49 days. This is a stream to watch, not a cycle to wait for.

44% of CELL AND GENE THERAPY CATAPULT’s awards go to a supplier it has used before.

Which is the argument for getting on the list rather than winning this one. The incumbent is rarely the last winner — it is the roster. See the retention odds by category →


You'll hear when CELL AND GENE THERAPY CATAPULT publishes Research & Development work again. One email per notice, unsubscribe in one click. We don’t use your address for anything else.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

CGTC is seeking a supplier to perform a Cryo-TEM assay on our samples and analysis.

CGTC want a supplier that can Quantify the quality of AAV samples with ns-TEM and cryo-TEM analyses, as well as assess overall morphology, including integrity, impurities, filled empty capsid ratio, genome length, and aggregation for AAV samples.

Before commencing a formal tender process, the CGTC are keen to seek market information from organisations that may have an interest or expertise in this field.

The information provided will be used to help inform and shape the requirements in our specification, as well as permitting us an understanding of what the market can provide.

Requirements

What the notice asks for

01

The information provided will be used

The information provided will be used to help inform and shape the requirements in our specification, as well as permitting us an understanding of what the market can provide.

Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at CELL AND GENE THERAPY CATAPULT, and generate a go-to-market strategy from their news, accounts and people.

Sign up free to unlock buyer intelligence

Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.

Deep dive · beta

The full intelligence dossier

Our agent reads CELL AND GENE THERAPY CATAPULT’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.

Sign up free to run a deep dive

Five included while we’re in beta, and the agent asks before it spends on any paid step.

Source & provenance
OCID
7a31bcc7-81a9-48d9-8025-cfb49f238740
Stage
preprocurement · Closed
Source
Contracts Finder
Buyer ref
CGTC-GUYS-LF-Premarketengagement-002-2023
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

This view needs WebGL, which this browser has turned off.

CELL AND GENE THERAPY CATAPULT’s tender network

This view needs WebGL, which this browser has turned off.
Also open now

Similar open tenders

Dynamic Purchasing System for the Provision of Insights for Behaviour Insights, Engagement and Research

Sunderland City Council

Closes 23 Feb 2029R&D
Value not publishedValue